-
1
-
-
8844261773
-
Long-term Survival Estimates for Imatinib versus Interferon-Alpha plus Low-Dose Cytarabine for Patients with Newly Diagnosed Chrnic-Phase Chromnic Myeloid leukemia
-
Anstrom KJ, Reed SD, Allen AS, Glendenning GA, Schulman KA. Long-term Survival Estimates for Imatinib versus Interferon-Alpha plus Low-Dose Cytarabine for Patients with Newly Diagnosed Chrnic-Phase Chromnic Myeloid leukemia. Cancer 2004 101 : 2584 92.
-
(2004)
Cancer
, vol.101
, pp. 2584-92
-
-
Anstrom, K.J.1
Reed, S.D.2
Allen, A.S.3
Glendenning, G.A.4
Schulman, K.A.5
-
3
-
-
33646004738
-
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in younger patiehts with good-prognosis diffuse large B-cell lymphoma: A randomised controlled trial by the Mabthera International Trial (MinT) Group
-
Pfreundschuh M, Trümper L, Österburg A et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in younger patiehts with good-prognosis diffuse large B-cell lymphoma: a randomised controlled trial by the Mabthera International Trial (MinT) Group. Lancet Oncol 2006 7 : 379 91.
-
(2006)
Lancet Oncol
, vol.7
, pp. 379-91
-
-
Pfreundschuh, M.1
Trümper, L.2
Österburg, A.3
-
4
-
-
23044503407
-
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes d'Adulte
-
Feugier P, Van Hoof A, Sebban C et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes d'Adulte. J Clin Oncol 2005 23 : 4117 26.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4117-26
-
-
Feugier, P.1
Van Hoof, A.2
Sebban, C.3
-
5
-
-
33749545033
-
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: Results of a prospective randomised phase 3 intergroup trial
-
Van Oers MHJ, Klasa R, Marcus RE et al. Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomised phase 3 intergroup trial. Blood 2006 108 : 3295 301.
-
(2006)
Blood
, vol.108
, pp. 3295-301
-
-
Van Oers, M.H.J.1
Klasa, R.2
Marcus, R.E.3
-
7
-
-
33947241348
-
Special considerations for haematology patients in relation to end-of-life care: Australian findings
-
Online First
-
McGrath P, Holewa H. Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care Online First, 2007.
-
(2007)
Eur J Cancer Care
-
-
McGrath, P.1
Holewa, H.2
-
8
-
-
34250373411
-
A model for end-of-life care in haematology: An Australian nursing perspective
-
McGrath P, Holewa H. A model for end-of-life care in haematology: An Australian nursing perspective. Oncol Nurs Forum 2007 34 : 79 85.
-
(2007)
Oncol Nurs Forum
, vol.34
, pp. 79-85
-
-
McGrath, P.1
Holewa, H.2
-
9
-
-
1642430607
-
Australasian haematologist referral patterns to palliative care: Lack of consensus on when and why
-
Auret K, Bulsara C, Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 2003 12 : 566 72.
-
(2003)
Intern Med J
, vol.12
, pp. 566-72
-
-
Auret, K.1
Bulsara, C.2
Joske, D.3
|